US Stock MarketDetailed Quotes
TLSA Tiziana Life Sciences
- 0.6300
- +0.0673+11.96%
Trading May 15 15:23 ET
64.95MMarket Cap-3705P/E (TTM)
0.6355High0.5702Low168.89KVolume0.6000Open0.5627Pre Close101.65KTurnover0.26%Turnover RatioLossP/E (Static)103.09MShares1.269952wk High11.67P/B40.44MFloat Cap0.410052wk Low--Dividend TTM64.19MShs Float24.3400Historical High--Div YieldTTM11.61%Amplitude0.4100Historical Low0.6010Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Tiziana Life Sciences Stock Forum
NEWS
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
Tiziana Life Sciences, a biotechnology company, files for Orphan Drug Designation for intranasal foralumab for treating non-active secondary progressive Multiple Sclerosis, aiming to be the first therapy to receive this designation. Supported by clinical evidence, the drug has shown positive results in an Expanded Access Program, improving fatigue in 70% of patients. A Phase 2a ...
NEWS
Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
Tiziana Life Sciences (TLSA) announces an upcoming oral presentation on the treatment of PIRA with Nasal Foralumab for Multiple Sclerosis at the AAN Annual Meeting. Presenter is Tarun Singhal from Harvard Medical School. The presentation aims to dampen microglial activation and stabilize clinical p...
No comment yet